Table 2.

Analysis of blood biochemical indicators between patients with and without alcohol consumption

Indicators	CPAa		p	CPBb		p	CPCc		p	Total (median)		p
	Yes	No		Yes	No		Yes	No		Yes	No
DAO (U/L)	2.38 (2.18–2.49)	1.94 (1.82–2.82)	0.441	2.41 (2.27–3.52)	2.24 (1.82–2.65)	0.217	1.71 (1.27–2.44)	2.83 (2.08–3.12)	0.035	2.38 (1.87–2.55)	2.24 (1.82–2.85)	0.825
d-lactate (mg/L)	13.24 (8.77–19.12)	10.14 (7.95–12.30)	0.017	8.08 (7.23–12.56)	8.68 (6.89–10.88)	0.959	9.99 (6.41–13.18)	11.85 (3.43–14.32)	1.000	9.99 (7.23–13.66)	10.04(7.41–12.72)	0.904
LPS (U/L)	8.09 (5.60–11.64)	3.74 (2.67–6.06)	0.008	7.38 (5.61–11.54)	6.22 (4.70–9.10)	0.413	11.99 (10.50–16.22)	11.48 (8.40–17.39)	0.780	9.52 (5.914–11.99)	6.06 (3.23–9.31)	0.006

^a,b,cPatients with Child–Pugh class A (n = 30), B (n = 31) and C (n = 19) hepatitis B or hepatitis B virus-related cirrhosis. Differences were analyzed using non-parametric Mann–Whitney U test